In brief: Methotrexate and liver fibrosis

Patients with type-2 diabetes who are receiving methotrexate for psoriasis have an increased risk of severe liver fibrosis, according to the results of a study in Sweden. Researchers reviewed 169 liver biopsies from 71 patients with psoriasis being treated with methotrexate. Of the 26 patients who had one or more of type-2 diabetes, overweight, alcohol over-consumption, or chronic hepatitis B or C, 25 developed fibrosis. Risk of fibrosis for psoriasis patients with one of these other conditions was elevated even when lower cumulative doses of methotrexate were used to treat them.
Rosenberg P, Urwitz H, Johannesson A et al. J Hepatol 2007;46:1111-18.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases